In CD4+ lymphocytes derived from individuals afflicted with Systemic Sclerosis (SSc), the application of a naturally occurring vitamin A derivative (all-trans retinoic acid) upregulates FOXP3 expression and, consequently, elevates the population of Tregs by inducing FOXP3 promoter demethylation (69), which may act as a target for treatment in SjS. The gene discussed is FOXP3; the disease is Schwartz-Jampel syndrome.